Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers

被引：0
作者：
K Metcalfe
S Gershman
H T Lynch
P Ghadirian
N Tung
C Kim-Sing
O I Olopade
S Domchek
J McLennan
A Eisen
W D Foulkes
B Rosen
P Sun
S A Narod
机构：
[1] Lawrence S Bloomberg Faculty of Nursing,Department of Preventive Medicine and Public Health
[2] University of Toronto,Department of Medicine
[3] Women's College Research Institute,Departments of Medicine and Genetics, Department of Hematology/Oncology
[4] Creighton University School of Medicine,undefined
[5] Epidemiology Research Unit,undefined
[6] Centre Hospitalier de Université de Montreal (CHUM),undefined
[7] Beth Israel Deaconess Medical Center,undefined
[8] BC Cancer Agency,undefined
[9] University of Chicago,undefined
[10] University of Pennsylvania,undefined
[11] Cancer Risk Program,undefined
[12] UCSF Comprehensive Cancer Center,undefined
[13] Toronto Sunnybrook Regional Cancer Center,undefined
[14] Program in Cancer Genetics,undefined
[15] McGill University,undefined
[16] University Health Network,undefined
来源：
British Journal of Cancer | 2011年 / 104卷
关键词：
breast cancer; BRCA1; BRCA2; contralateral breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1384 / 1392
页数：8
相关论文
共 221 条
[1]  
Brekelmans CT(2007)Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer cases Eur J Cancer 43 867-876
[2]  
Tilanus-Linthorst MM(2007)Age at menarche and menopause and breast cancer risk in the International BRCA1/2 Carrier Cohort Study Cancer Epidemiol Biomarkers Prev 16 740-746
[3]  
Seynaeve C(2005)Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study J Clin Oncol 23 7491-7496
[4]  
vd Ouweland A(1998)Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium Am J Hum Genet 62 676-689
[5]  
Menke-Pluymers MB(2009)Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers J Clin Oncol 27 5887-5892
[6]  
Bartels CC(2006)Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update Int J Cancer 118 2281-2284
[7]  
Kriege M(2002)Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status Lancet 359 1471-1477
[8]  
van Geel AN(2010)Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2 J Clin Oncol 28 2404-2410
[9]  
Burger CW(2010)Family history of cancer and cancer risks in women with BRCA1 or BRCA2 mutations J Natl Cancer Inst 102 1874-1878
[10]  
Eggermont AM(2004)Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers J Clin Oncol 22 2328-2335
12345678910